Search results
Jul 1, 2024 · Amneal is a pharmaceutical company that offers over 280 generic and specialty products, including naloxone nasal spray. Learn more about their products, culture, news and opportunities.
- Generic Products
We distribute our products through deeply-held relationships...
- Our Story
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully...
- Investor Relations
Amneal is a global, diversified pharmaceutical company that...
- News
Selecting a year value will change the news content. Select...
- Customer Login
©1991-2024 CDI Technology, LLC. ... The portal allows for...
- Products We create essential medicines
We are also excited about our work to bring patients more...
- Quality
Integrity – We deliver quality pharmaceuticals that are safe...
- Drug Safety
We are focused on the safety and well-being of patients. To...
- About
About. AboutWe challenge convention so healthy can be...
- Generic Products
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
About. AboutWe challenge convention so healthy can be possible. Our Story. Amneal at-a-glance. Our Founders. Our Milestones. Our Purpose & Commitments. Our Culture. Rise, Lead, Succeed.
Get the latest Amneal Pharmaceuticals Inc (AMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jul 1, 2024 · Builds on U.S. biosimilar portfolio of seven products with three commercial and four in pipeline 8th biosimilar expands portfolio into allergy treatments, a new therapeutic area Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the addition of omalizumab, referencing XOLAIR ® , to its biosimilar pipeline. Omalizumab is a humanized monoclonal ...
People also ask
Who is Amneal Pharmaceuticals?
What happened to Amneal Pharmaceuticals?
Where is Amneal Pharmaceuticals Private Limited located?
Does Amneal have omalizumab?
Jul 1, 2024 · 8th biosimilar expands portfolio into allergy treatments, a new therapeutic area. BRIDGEWATER, N.J., July 01, 2024 -- ( BUSINESS WIRE )--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or ...